Versant Ventures Announces Acquisition of Cell Therapy Company BlueRock Therapeutics

 

Versant Ventures Announces Acquisition of Cell Therapy Company BlueRock Therapeutics

Since the firm’s founding in 1999, 75 Versant companies have achieved successful acquisitions or IPOs. Versant is currently investing out of its seventh fund, Versant Venture Capital VII, a $600 …

More Versant Ventures Announces Acquisition of Cell Therapy Company BlueRock Therapeutics Videos

Leave a Reply